1. Home
  2. MRK vs CCIA Comparison

MRK vs CCIA Comparison

Compare MRK & CCIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRK
  • CCIA
  • Stock Information
  • Founded
  • MRK 2000
  • CCIA N/A
  • Country
  • MRK United States
  • CCIA
  • Employees
  • MRK N/A
  • CCIA N/A
  • Industry
  • MRK Biotechnology: Pharmaceutical Preparations
  • CCIA
  • Sector
  • MRK Health Care
  • CCIA
  • Exchange
  • MRK Nasdaq
  • CCIA Nasdaq
  • Market Cap
  • MRK 198.5B
  • CCIA N/A
  • IPO Year
  • MRK N/A
  • CCIA 2023
  • Fundamental
  • Price
  • MRK $81.00
  • CCIA N/A
  • Analyst Decision
  • MRK Buy
  • CCIA
  • Analyst Count
  • MRK 15
  • CCIA 0
  • Target Price
  • MRK $113.71
  • CCIA N/A
  • AVG Volume (30 Days)
  • MRK 18.0M
  • CCIA N/A
  • Earning Date
  • MRK 07-29-2025
  • CCIA N/A
  • Dividend Yield
  • MRK 4.00%
  • CCIA N/A
  • EPS Growth
  • MRK 667.14
  • CCIA N/A
  • EPS
  • MRK 6.88
  • CCIA N/A
  • Revenue
  • MRK $63,922,000,000.00
  • CCIA N/A
  • Revenue This Year
  • MRK $2.42
  • CCIA N/A
  • Revenue Next Year
  • MRK $5.77
  • CCIA N/A
  • P/E Ratio
  • MRK $11.77
  • CCIA N/A
  • Revenue Growth
  • MRK 4.10
  • CCIA N/A
  • 52 Week Low
  • MRK $73.31
  • CCIA N/A
  • 52 Week High
  • MRK $129.93
  • CCIA N/A
  • Technical
  • Relative Strength Index (RSI)
  • MRK 54.36
  • CCIA 51.33
  • Support Level
  • MRK $78.14
  • CCIA $25.55
  • Resistance Level
  • MRK $83.07
  • CCIA $25.70
  • Average True Range (ATR)
  • MRK 1.84
  • CCIA 0.12
  • MACD
  • MRK 0.21
  • CCIA 0.01
  • Stochastic Oscillator
  • MRK 64.15
  • CCIA 69.26

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

About CCIA Carlyle Credit Income Fund 8.75% Series A Preferred Shares due 2028

Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing predominantly in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting mainly of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.

Share on Social Networks: